Teva Pharmaceutical Industries - Stock

Teva Pharmaceutical Industries P/S 2024

Teva Pharmaceutical Industries P/S

117.52

Ticker

TEVA.TA

ISIN

IL0006290147

WKN

906517

As of Jun 30, 2024, Teva Pharmaceutical Industries's P/S ratio stood at 117.52, a 127.22% change from the 51.72 P/S ratio recorded in the previous year.

The Teva Pharmaceutical Industries P/S history

Teva Pharmaceutical Industries Aktienanalyse

What does Teva Pharmaceutical Industries do?

Teva Pharmaceutical Industries Ltd is a leading global company in the pharmaceutical industry. The company was founded in 1901 in Jerusalem, Israel, as Salomon, Levin and Company. The name Teva was adopted later in 1976. Teva's business model focuses on manufacturing and distributing high-quality and affordable pharmaceuticals worldwide. The company specializes in generics, as well as specialty pharmaceuticals. Teva has made a name for itself through its strong brand presence, focus on developing affordable medications, and production of biosimilars. Teva is divided into various divisions that focus on the manufacturing and distribution of pharmaceuticals. One of these divisions is the generics division, in which the company targets both the domestic and international markets. Teva's research and development division is known for developing biotechnology-based medications. The specialty pharmaceuticals division focuses on rare and difficult-to-treat diseases, such as multiple sclerosis and Parkinson's disease, and develops new treatment options. Teva is also commercially active in the field of biosimilars, which offer medications based on biological sources. These medications offer higher efficacy and fewer side effects than conventional medications. Teva has taken a leading role in this division by offering medications with high standards, serving a significant growth market. The company offers a variety of products, including prescription medications, over-the-counter products, and veterinary medicine. Some of Teva's popular products include Azilect (a medication for Parkinson's treatment), Copaxone (a medication for multiple sclerosis treatment), QVAR (a medication for asthma treatment), Azor (a medication for hypertension treatment), and ProAir (a medication for asthma treatment). Teva has a long-standing history in the pharmaceutical industry and has established an impressive global presence. The company has strong structures not only in Israel but also in other countries such as the United States, Europe, and Asia. It has maintained an impressive growth strategy and has become a major player in global healthcare. Overall, Teva has established itself as a key company in the pharmaceutical industry. It has a strong focus on affordability and quality of medications, with particular emphasis on the development of biosimilars and biotechnology. The company has a wide range of products and divisions that cater to the needs of customers worldwide. Teva Pharmaceutical Industries ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/S Details

Decoding Teva Pharmaceutical Industries's P/S Ratio

Teva Pharmaceutical Industries's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.

Year-to-Year Comparison

Comparing Teva Pharmaceutical Industries's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.

Impact on Investments

The P/S ratio is instrumental for investors evaluating Teva Pharmaceutical Industries's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.

Interpreting P/S Ratio Fluctuations

Variations in Teva Pharmaceutical Industries’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.

Frequently Asked Questions about Teva Pharmaceutical Industries Stock

What is the price-to-earnings ratio of Teva Pharmaceutical Industries?

The price-earnings ratio of Teva Pharmaceutical Industries is currently 117.52.

How has the price-earnings ratio of Teva Pharmaceutical Industries changed compared to last year?

The price-to-earnings ratio of Teva Pharmaceutical Industries has increased by 127.22% increased compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Teva Pharmaceutical Industries high compared to other companies?

Yes, the price-to-earnings ratio of Teva Pharmaceutical Industries is high compared to other companies.

How does an increase in the price-earnings ratio of Teva Pharmaceutical Industries affect the company?

An increase in the price-earnings ratio of Teva Pharmaceutical Industries would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Teva Pharmaceutical Industries affect the company?

A decrease in the price-earnings ratio of Teva Pharmaceutical Industries would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Teva Pharmaceutical Industries?

Some factors that influence the price-earnings ratio of Teva Pharmaceutical Industries are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Teva Pharmaceutical Industries pay?

Over the past 12 months, Teva Pharmaceutical Industries paid a dividend of 3.1 USD . This corresponds to a dividend yield of about 0.19 %. For the coming 12 months, Teva Pharmaceutical Industries is expected to pay a dividend of 0 USD.

What is the dividend yield of Teva Pharmaceutical Industries?

The current dividend yield of Teva Pharmaceutical Industries is 0.19 %.

When does Teva Pharmaceutical Industries pay dividends?

Teva Pharmaceutical Industries pays a quarterly dividend. This is distributed in the months of April, July, September, December.

How secure is the dividend of Teva Pharmaceutical Industries?

Teva Pharmaceutical Industries paid dividends every year for the past 3 years.

What is the dividend of Teva Pharmaceutical Industries?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Teva Pharmaceutical Industries located?

Teva Pharmaceutical Industries is assigned to the 'Health' sector.

Wann musste ich die Aktien von Teva Pharmaceutical Industries kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Teva Pharmaceutical Industries from 12/12/2017 amounting to 0.298 USD, you needed to have the stock in your portfolio before the ex-date on 11/28/2017.

When did Teva Pharmaceutical Industries pay the last dividend?

The last dividend was paid out on 12/12/2017.

What was the dividend of Teva Pharmaceutical Industries in the year 2023?

In the year 2023, Teva Pharmaceutical Industries distributed 0 USD as dividends.

In which currency does Teva Pharmaceutical Industries pay out the dividend?

The dividends of Teva Pharmaceutical Industries are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Teva Pharmaceutical Industries

Our stock analysis for Teva Pharmaceutical Industries Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Teva Pharmaceutical Industries Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.